IF YOU HAVE COPD, YOU SHOULD GET SCREENED FOR ALPHA-1.
The AlphaID™ At Home Genetic Health Risk Service detects your risk for genetic COPD, a condition called alpha-1 antitrypsin deficiency (AATD), or alpha-1.
The Genetic Factor
Sometimes, emphysema and COPD are hereditary conditions, passed from parents to their biological children. So whether you smoked or not, or were exposed to disease-causing environmental factors or not, you can still develop alpha-1 because it is inherited.
Similar Symptoms, Serious Damage
People with traditional COPD may experience coughing, wheezing, and trouble breathing. The symptoms of alpha-1 are often just like those of traditional COPD, so people with alpha-1 often go undiagnosed. But having low levels of alpha-1 antitrypsin can leave your lungs vulnerable to serious damage.
Experts Agree, Screening Is Key
According to the COPD Foundation, the World Health Organization (WHO), the American Thoracic Society, and the GOLD COPD guidelines, if you've been diagnosed with COPD, you should learn if you are at risk of alpha-1.1-4
New Possibilities
Knowing your risk could open the door to new options. If you’re diagnosed with alpha-1, your healthcare provider may help you consider lifestyle changes and FDA-approved treatments.
“For many COPD patients, genetics are often overlooked due to their history of exposure to harmful environmental factors like smoking. As it turns out, more than 90% of people in the US who have genetic COPD don't know they have it. With an at-home screening kit like AlphaID At Home Genetic Health Risk Service, learning your risk has never been easier.”
See how easy it is to discover your risk for alpha-1.
With AlphaID™ At Home, you simply collect a small saliva sample by swabbing along your gumline. Ready to discover your risk for alpha-1? Watch an overview of the process in this quick video.
Order
Start today by ordering your free kit, which contains all the supplies you need to collect and mail your saliva sample.*
Register
Register your kit online, using your kit’s unique ID number.
Collect
Collect your saliva sample in the privacy and convenience of home. All it takes is a quick swab of your gumline.
Return
Mail your sample to the lab. The postage and lab processing are also included at at no charge. Just pop it in your mailbox.
Receive
You will receive an email when your sample is received and another when your report is ready.
View
Log on to your confidential account to securely view your report.
Along the way, we'll provide helpful updates. Don’t wait another day to learn your risk for alpha-1. Start by taking the first step to learning your risk: Order your free at-home screening kit today.
“Alpha-1-related COPD can only be distinguished from traditional COPD using genetic testing. With a free, at-home screening kit like AlphaID At Home Genetic Health Risk Service, patients can learn their risk for alpha-1, which may change how they manage their condition, and identify a family at risk.”
Your privacy is protected.
The AlphaID At Home Genetic Health Risk Service is FDA cleared and HIPAA compliant. The site is secure and confidential. Your report is only accessible by you, on the website, using the password you create when registering.
Take a look inside.
What’s included with the AlphaID™ At Home Saliva Collection Kit? Watch this brief video to peek inside.
If you learn you’re at risk, talk with your healthcare provider.
Only a healthcare professional can diagnose alpha-1, so regardless of your risk, be sure to share your results with them. If you are diagnosed with alpha-1, there may be FDA-approved treatment options to consider with your healthcare provider.† Download a free discussion guide to help start the conversation.
Want to know more about genetic COPD screening?
Sign up to learn more about the free AlphaID At Home Service. We’ll show you how easily AlphaID At Home can help you learn your risk for genetic COPD.
*The AlphaID At Home Genetic Health Risk Service, including the kit, is provided for free and may not be billed to patients or their insurers. There is no obligation to purchase or use any product or service offered by any manufacturer.
†Talk to your healthcare provider about possible treatment options.
References
- American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003 Oct 1;168(7):818-900.
- Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. GOLD COPD 2021 report.
- Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682.
- World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Org. 1997;75(5):397-415.